Diversity in Individual Src-family Kinase Regulation: Opportunities for Selective Inhibitor Discovery

被引：0
|
作者：
Moroco, J. A. [1 ]
Craigo, J. K. [1 ]
Gray, N. S. [2 ]
Smithgall, T. E. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med Microbiol & Mol Genet, Pittsburgh, PA USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol,Dept Canc Biol, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72023-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
225
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck
    Wityak, J
    Das, J
    Moquin, RV
    Shen, ZQ
    Lin, J
    Chen, P
    Doweyko, AM
    Pitt, S
    Pang, SH
    Shen, DR
    Fang, Q
    de Fex, HF
    Schieven, GL
    Kanner, SB
    Barrish, JC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 4007 - 4010
  • [42] Dynamic regulation of Src-family kinases by CD45 in B cells
    Shrivastava, P
    Katagiri, T
    Ogimoto, M
    Mizuno, K
    Yakura, H
    BLOOD, 2004, 103 (04) : 1425 - 1432
  • [43] Positive and negative regulation of Src-family membrane kinases by CD45
    Thomas, ML
    Brown, EJ
    IMMUNOLOGY TODAY, 1999, 20 (09): : 406 - 411
  • [44] Evidence for Src-family tyrosine kinase and MAP kinase activity in Pseudomonas aeruginosa host cell invasion
    Fleiszig, SMJ
    Kuo, TC
    Phung, KT
    Wu, J
    Van, R
    Evans, DJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S793 - S793
  • [45] The Src-family tyrosine kinase inhibitor PP1 interferes with the activation of ribosornal protein S6 kinases
    Shah, OJ
    Kimball, SR
    Jefferson, LS
    BIOCHEMICAL JOURNAL, 2002, 366 : 57 - 62
  • [46] TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product Attributes
    Lamture, Gauri
    Baer, Alan
    Fischer, Joseph W.
    Colon-Moran, Winston
    Bhattarai, Nirjal
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (03) : 139 - 149
  • [47] A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer
    Secord, Angeles Alvarez
    Teoh, Deanna K.
    Barry, William T.
    Yu, Miao
    Broadwater, Gloria
    Havrilesky, Laura J.
    Lee, Paula S.
    Berchuck, Andrew
    Lancaster, Johnathan
    Wenham, Robert M.
    CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5489 - 5498
  • [48] Cocrystallization of the Src-Family Kinase Hck with the ATP-Site Inhibitor A-419259 Stabilizes an Extended Activation Loop Conformation
    Selzer, Ari M.
    Alvarado, John J.
    Smithgall, Thomas E.
    BIOCHEMISTRY, 2024, 63 (20) : 2594 - 2601
  • [49] In Vitro Evolution Reveals a Single Mutation as Sole Source of Src-Family Kinase C-Helix-out Inhibitor Resistance
    Patel, Ravi K.
    Patel, Yash K.
    Smithgall, Thomas E.
    ACS CHEMICAL BIOLOGY, 2020, 15 (08) : 2175 - 2184
  • [50] Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
    Hildo C. Lantermans
    Marthe Minderman
    Annemieke Kuil
    Marie-José Kersten
    Steven T. Pals
    Marcel Spaargaren
    Leukemia, 2021, 35 : 881 - 886
12345